ストックスクリーナーアプリを入手
7.56
2.45%
-0.19
プレマーケット:
7.56
Neuraxis Inc (NRXS) 最新ニュース
Craig-Hallum Maintains Neuraxis(NRXS.US) With Buy Rating, Maintains Target Price $13 - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com
NeurAxis secures major insurer coverage for IB-Stim device - Investing.com
NeurAxis secures major insurer coverage for IB-Stim device By Investing.com - Investing.com India
NeurAxis Announces Medical Coverage Policy Milestone, - GlobeNewswire
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives - Yahoo Finance
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference - Yahoo Finance
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock? - TradingView
NeurAxis at iAccess Alpha conference: payer wins drive growth By Investing.com - Investing.com Nigeria
NRXS: Strong insurance coverage and clinical data position the company for rapid growth through 2027 - tradingview.com
NeurAxis at iAccess Alpha conference: payer wins drive growth - Investing.com
Is Kodak having a "Kodak moment?" 2 watchlist stocks. - TradingView
NRXS Forecast & Price Target - TradingKey
Neuraxis Inc. (NRXS) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Neuraxis Inc. (NRXS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Neuraxis Inc. (NRXS) Peer Comparison – Compare with Others - Value Research
Neuraxis Inc. (NRXS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Neuraxis | 4: Statement of changes in beneficial ownership of securities-Officer Carrico Thomas Joeseph - Moomoo
Neuraxis (NRXS) Q2 2026 Earnings: EPS Beats Its Estimate in the Latest Session; Price Move: Shares Finish 1.91% Down in the Current UpdateEarnings Expansion Phase - vinanet.vn
NeurAxis Earnings Call Signals High Growth, High Hurdles - TipRanks
NeurAxis Enhances Executive and Director Equity Compensation - TipRanks
Neuraxis (NRXS) grants CEO 199K instantly vesting stock units - Stock Titan
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up - NewsBreak: Local News & Alerts
Neuraxis (NRXS) Q2 2026 Earnings: Narrower Loss Beats Estimates, Stock Jumps 32%Performance Review - vinanet.vn
NRXS Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 32% Stock SurgeEarnings Per Share - vinanet.vn
Neuraxis Inc. (NRXS) Q2 2026 Earnings: Narrower Loss Beats Expectations as Stock Holds SteadyStrong Earnings Momentum - vinanet.vn
NRXS Q2 2026 Earnings: 41.79% EPS Beat Signals Cost Discipline, Yet Shares Slip 1.26%Return On Assets - vinanet.vn
NeurAxis revenues up 116% to USD 1.9M in Q2 2026 - Medical Buyer
NeurAxis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
NeurAxis (NRXS) Q2 2026 Earnings Call Transcript - The Globe and Mail
Could NeurAxis (NASDAQ:NRXS) Reshape Nasdaq Composite Focus? - Kalkine Media
Transcript : NeurAxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
NeurAxis (NASDAQ:NRXS): What Could Today’s Update Reveal About Pediatric Therapy Adoption And Reimbursement? - Kalkine Media
NRXS: Q2 revenue up 116% YoY, gross margin at 85.9%, with payer coverage and VA expansion driving growth - TradingView
Earnings call transcript: NeurAxis falls on Q2 2026 EPS miss despite 116% revenue growth - Investing.com
NeurAxis reports 116% revenue growth in second quarter 2026 By Investing.com - Investing.com Nigeria
NeurAxis reports 116% revenue growth in second quarter 2026 - Investing.com
NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth - The Manila Times
NRXS: Q2 2026 revenue surged 116% year-over-year, with gross margin up to 85.9% and strong cash position - TradingView
NRXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NeurAxis (NYSE American: NRXS) doubles sales yet warns on going concern - Stock Titan
Earnings To Watch: Neuraxis Inc (NRXS) Q2 2026 -- GF Value Sees 55% Downside - Yahoo Finance
NeurAxis, Inc. (NRXS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
NeurAxis宣佈爲IB-Stim PENFS療法增加美國中大西洋地區的覆蓋範圍，將服務擴展至超過500,000人 - Moomoo
Neuraxis Expands Payer Coverage for Percutaneous Electrical Nerve Field Stimulation and Ib-Stim Treatment - marketscreener.com
NeurAxis Expands Payer Coverage with New Policies - GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Neuraxis Q1 2026 Earnings: Narrower-Than-Expected Loss as EPS Beats Consensus by 7.12%Guidance Revision Trend - dars.gov.et
NRXS|Neuraxis Inc|Price:6.735|Chg%:+0.485 - TradingKey
Neuraxis Inc (NRXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NRXS Q1 2026 Earnings: Narrower-than-Expected Loss Despite Stock DeclineCFO Commentary Report - dars.gov.et
NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 - The Manila Times
NeurAxis, Inc. to Report Second Quarter 2026 Financial Results on August 11 and Host Conference Call - Quiver Quantitative
Neuraxis Inc (NRXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuraxis Inc (NRXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neuraxis Inc (NRXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuraxis Inc (NRXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NRXS|Neuraxis Inc|Price:6.800| - TradingKey
Neuraxis Inc (NRXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):